11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
If you’ve had occasion to converse with a management-side employment lawyer (and somehow survived i...
Read More >
Signaling a growing movement to align culturally inclusive practices with legal protections, Califor...
Read More >
At a time of crisis and economic upheaval, there is a natural tendency for people to pull together. ...
Read More >
As scheduled, EEOC and NORC have now provided employers with a way batch upload their EEO-1 Componen...
Read More >
As previewed in the Spring regulatory agenda, the Office of Federal Compliance Contract Programs (OF...
Read More >
Both New Jersey and New York State have recently passed legislation restricting employers from obtai...
Read More >